SpyGlass Pharma (SGP) Reports Q2 Loss of $0.59
Tweet
Share
E-mail
Get Alerts SGP Hot Sheet
Join SI Premium – FREE
SpyGlass Pharma (NASDAQ: SGP) reported Q2 EPS of ($0.59).
For earnings history and earnings-related data on SpyGlass Pharma (SGP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Reiterates Overweight Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)
- U.S. and Denmark close in on a Greenland deal - Reuters
- BNP Paribas Exane Resumes Hugo Boss (BOSS:GR) (BOSSY) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
